US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

54.08

+0.39000.73%

Post-market: 54.080.00000.00%19:44 EDT

Volume:1.95M

Turnover:105.64M

Market Cap:13.40B

PE:17.01

High:54.68

Open:53.74

Low:53.70

Close:53.69

52wk High:57.57

52wk Low:33.76

Shares:247.78M

Float Shares:214.00M

Volume Ratio:0.93

T/O Rate:0.91%

Dividend:- -

Dividend Rate:- -

EPS(TTM):3.18

EPS(LYR):2.78

ROE:44.39%

ROA:23.97%

PB:7.27

PE(LYR):19.45

Loading ...

Overview Company News Filings

Exelixis (EXEL) Gets a Hold from Wells Fargo

Exelixis Kept at Hold as Cabo Momentum Offsets Pipeline Uncertainty; Price Target Raised from $49 to $50

Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT), Henry Schein (HSIC) and Exelixis (EXEL)

Margin Gains From Oncology Portfolio Might Change The Case For Investing In Exelixis (EXEL)

Simply Wall St.

Exelixis Price Target Raised to $55 on Cabo Strength, Buyback-Driven EPS Growth, and Zanzalintinib Upside Optionality

Exelixis Inc reports results for the quarter ended March 31 - Earnings Summary

Exelixis Posts Strong Q1 Results, Expands Share Buybacks

Exelixis Q1 revenue slightly beats estimates

GUIDANCE: (EXEL) Exelixis Expects Full Year 2026 Revenue Range $2.53B - $2.63B, vs. FactSet Est of $2.58B

MT Newswires Live

Exelixis Q1 FY26 GAAP diluted EPS climbs to $0.79; revenue rises to $610.8 million

Exelixis Q1 Adj. EPS $0.87 Beats $0.70 Estimate, Sales $610.812M Beat $605.196M Estimate

Benzinga Earnings

BRIEF-Exelixis Q1 Revenue USD 610.8 Million Vs. IBES Estimate USD 605.2 Million

Exelixis Guidance 2026 Total Revenues $2.525 Billion - $2.625 Billion

THOMSON REUTERS

Exelixis Inc - Maintains 2026 Financial Guidance

THOMSON REUTERS

Exelixis Inc - in May, Board Authorizes $750 Mln Stock Repurchase Program in May 2026

THOMSON REUTERS

Exelixis Inc - Initiates Stellar-201 Phase 2 Trial of Zanzalintinib in Recurrent Meningioma

THOMSON REUTERS

Earning Preview: Exelixis Q1 revenue is expected to increase by 21.51%, and institutional views are cautious with Hold calls dominant

Exelixis and Merck Advance Key Phase 3 Kidney Cancer Trial, Setting Up a New Catalyst for EXEL

Does Exelixis (EXEL) Gain Quiet Competitive Leverage From a Rival’s Kidney Cancer Setback?

Simply Wall St.

The Tactical Trio Blueprint For Solid Balance Sheet And Fundamentals

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/EXEL/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EXEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","market":"US","secType":"STK","nameCN":"Exelixis","latestPrice":54.08,"timestamp":1787342400000,"preClose":53.69,"halted":0,"volume":1949764,"hourTrading":{"tag":"盘后","latestPrice":54.08,"preClose":54.08,"latestTime":"19:44 EDT","volume":58991,"amount":3189593.18682,"timestamp":1787355873398,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.007263922518159817,"floatShares":214000000,"shares":247781692,"eps":3.18,"marketStatus":"Market Closed","change":0.39,"latestTime":"08-21 16:00:00 EDT","open":53.74,"high":54.68,"low":53.7,"amount":105637127.501452,"amplitude":0.018253,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":3.18,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":955425600000,"exchange":"NASDAQ","adjPreClose":53.69,"preHourTrading":{"tag":"盘前","latestPrice":53.98,"preClose":53.69,"latestTime":"09:06 EDT","volume":1167,"amount":63006.621750000006,"timestamp":1787317603761,"change":0.29,"changeRate":0.005401,"amplitude":0.029056},"postHourTrading":{"tag":"盘后","latestPrice":54.08,"preClose":54.08,"latestTime":"19:44 EDT","volume":58991,"amount":3189593.18682,"timestamp":1787355873398,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9320162428705547,"optionData":{"bulkOrders":[{"symbol":"EXEL","call":true,"expireDate":1789704000000,"strike":"60.0","timestamp":1787324989191,"price":0.6,"volume":1929,"amount":115740,"type":"+"}]},"impliedVol":0.4067,"impliedVolPercentile":0.6215},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EXEL\",,,,,undefined,":{"symbol":"EXEL","floatShares":214000000,"roa":"23.97%","roe":"44.39%","lyrEps":2.78,"volumeRatio":0.9320162428705547,"shares":247781692,"dividePrice":0,"high":54.68,"amplitude":0.018253,"preClose":53.69,"low":53.7,"week52Low":33.755,"pbRate":"7.27","psRate":"5.50","week52High":57.57,"institutionHeld":0.828,"latestPrice":54.08,"eps":3.18,"divideRate":0,"volume":1949764,"delay":0,"ttmEps":3.18,"open":53.74,"prevYearClose":43.83,"prevWeekClose":51.24,"prevMonthClose":53.03,"prevQuarterClose":54.41,"fiveDayClose":51.24,"twentyDayClose":55.37,"sixtyDayClose":50.03},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EXEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"EXEL","fiscalQuarterEnding":"2026/06","expectedEps":0.75,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":0.82},{"market":"US","date":"2026-05-05","symbol":"EXEL","fiscalQuarterEnding":"2026/03","expectedEps":0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":0.79},{"market":"US","date":"2026-02-10","symbol":"EXEL","fiscalQuarterEnding":"2025/12","expectedEps":0.68,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1770699600000,"reportTimeType":"post","actualEps":0.48},{"market":"US","date":"2026-01-11","symbol":"EXEL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1768107600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-04","symbol":"EXEL","fiscalQuarterEnding":"2025/09","expectedEps":0.59,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.67}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EXEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EXEL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0952,"buy":0.2381,"hold":0.619,"sell":0.0476,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.619,"analysts":21,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EXEL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EXEL","date":"2026-08-21","current":17.006289,"percent":0.069805,"low":13.520237,"twenty":17.393,"median":21.779709,"eighty":35.430434,"high":81.497549,"avg":28.98499,"sd":16.009169,"marketCap":13303399043},"quantilePoints":[{"date":"2021-08-27","current":65.092863,"twenty":-27.329077,"median":14.633356,"eighty":40.76874,"marketCap":6121397950},{"date":"2021-09-03","current":66.231905,"twenty":-27.329077,"median":14.930088,"eighty":41.024831,"marketCap":6228514538},{"date":"2021-09-10","current":66.868428,"twenty":-27.329077,"median":15.002715,"eighty":41.184268,"marketCap":6288373808},{"date":"2021-09-17","current":69.41452,"twenty":-27.329077,"median":15.270884,"eighty":41.645802,"marketCap":6527810887},{"date":"2021-09-24","current":68.174975,"twenty":-27.329077,"median":15.454005,"eighty":42.220717,"marketCap":6411242835},{"date":"2021-10-01","current":72.16162,"twenty":-27.329077,"median":15.627908,"eighty":42.663031,"marketCap":6786150893},{"date":"2021-10-08","current":72.42963,"twenty":-27.329077,"median":15.773963,"eighty":43.366777,"marketCap":6811354796},{"date":"2021-10-15","current":73.099654,"twenty":-27.329077,"median":15.952475,"eighty":44.822559,"marketCap":6874364554},{"date":"2021-10-22","current":71.692603,"twenty":-27.329077,"median":16.00116,"eighty":45.312226,"marketCap":6742044063},{"date":"2021-10-29","current":72.061116,"twenty":-27.329077,"median":16.265432,"eighty":45.826118,"marketCap":6776699429},{"date":"2021-11-05","current":37.285528,"twenty":-27.329077,"median":16.391679,"eighty":45.919924,"marketCap":6125452889},{"date":"2021-11-12","current":34.858887,"twenty":-27.329077,"median":16.479897,"eighty":45.919924,"marketCap":5726792216},{"date":"2021-11-19","current":34.724073,"twenty":-27.329077,"median":16.682751,"eighty":45.919924,"marketCap":5704644400},{"date":"2021-11-26","current":32.855945,"twenty":-27.200425,"median":16.81027,"eighty":45.919924,"marketCap":5397738961},{"date":"2021-12-03","current":30.506341,"twenty":-26.943119,"median":16.933764,"eighty":45.919924,"marketCap":5011734182},{"date":"2021-12-10","current":32.066324,"twenty":-26.245177,"median":17.104522,"eighty":45.919924,"marketCap":5268016044},{"date":"2021-12-17","current":35.051477,"twenty":-24.694911,"median":17.218287,"eighty":45.919924,"marketCap":5758431952},{"date":"2021-12-23","current":37.131455,"twenty":-24.254275,"median":17.32582,"eighty":45.919924,"marketCap":6100141100},{"date":"2021-12-31","current":35.20555,"twenty":7.517288,"median":17.464132,"eighty":45.919924,"marketCap":5783743740},{"date":"2022-01-07","current":36.091466,"twenty":7.709485,"median":17.687208,"eighty":45.891374,"marketCap":5929286526},{"date":"2022-01-14","current":34.897405,"twenty":7.799575,"median":17.756166,"eighty":45.891374,"marketCap":5733120163},{"date":"2022-01-21","current":33.356681,"twenty":7.907699,"median":17.862859,"eighty":45.891374,"marketCap":5480002275},{"date":"2022-01-28","current":34.223338,"twenty":7.943549,"median":18.081923,"eighty":45.891374,"marketCap":5622381087},{"date":"2022-02-04","current":36.187761,"twenty":8.039903,"median":18.360975,"eighty":45.891374,"marketCap":5945106394},{"date":"2022-02-11","current":36.110725,"twenty":8.136529,"median":18.515656,"eighty":45.891374,"marketCap":5932450500},{"date":"2022-02-18","current":27.042003,"twenty":8.217909,"median":18.789229,"eighty":45.891374,"marketCap":6248406283},{"date":"2022-02-25","current":27.899162,"twenty":8.270506,"median":18.897922,"eighty":45.891374,"marketCap":6446464151},{"date":"2022-03-04","current":28.61807,"twenty":8.371042,"median":19.106053,"eighty":45.891374,"marketCap":6612577201},{"date":"2022-03-11","current":29.019,"twenty":8.507031,"median":19.335948,"eighty":45.891374,"marketCap":6705217172},{"date":"2022-03-18","current":29.572006,"twenty":8.621808,"median":21.199768,"eighty":45.891374,"marketCap":6832996441},{"date":"2022-03-25","current":30.249439,"twenty":8.73225,"median":22.506564,"eighty":45.891374,"marketCap":6989526047},{"date":"2022-04-01","current":31.645779,"twenty":8.756029,"median":22.697854,"eighty":45.891374,"marketCap":7312168702},{"date":"2022-04-08","current":31.825506,"twenty":8.792498,"median":22.852188,"eighty":45.891374,"marketCap":7353696965},{"date":"2022-04-14","current":31.995647,"twenty":8.865935,"median":22.952956,"eighty":45.891374,"marketCap":7393010230},{"date":"2022-04-22","current":31.067233,"twenty":8.939729,"median":23.213643,"eighty":45.891374,"marketCap":7178488062},{"date":"2022-04-29","current":30.956378,"twenty":8.974263,"median":23.420305,"eighty":45.891374,"marketCap":7152873475},{"date":"2022-05-06","current":29.778539,"twenty":9.039592,"median":23.531551,"eighty":45.891374,"marketCap":6880718486},{"date":"2022-05-13","current":21.60979,"twenty":9.09473,"median":23.549925,"eighty":45.891374,"marketCap":6440473677},{"date":"2022-05-20","current":19.113041,"twenty":9.107191,"median":23.549925,"eighty":45.891374,"marketCap":5696355204},{"date":"2022-05-27","current":19.801799,"twenty":9.125872,"median":23.549925,"eighty":45.891374,"marketCap":5901629266},{"date":"2022-06-03","current":20.490558,"twenty":9.145972,"median":23.549925,"eighty":45.891374,"marketCap":6106903327},{"date":"2022-06-10","current":19.521991,"twenty":9.183299,"median":23.549925,"eighty":45.891374,"marketCap":5818236678},{"date":"2022-06-17","current":19.973989,"twenty":9.197529,"median":23.549925,"eighty":45.891374,"marketCap":5952947781},{"date":"2022-06-24","current":23.912825,"twenty":9.237499,"median":23.564333,"eighty":45.919924,"marketCap":7126858820},{"date":"2022-07-01","current":23.213305,"twenty":9.247736,"median":23.584442,"eighty":45.919924,"marketCap":6918377351},{"date":"2022-07-08","current":23.686826,"twenty":9.281845,"median":23.611294,"eighty":45.919924,"marketCap":7059503269},{"date":"2022-07-15","current":22.965782,"twenty":9.328108,"median":23.611294,"eighty":45.919924,"marketCap":6844606986},{"date":"2022-07-22","current":22.449214,"twenty":9.353834,"median":23.633017,"eighty":45.919924,"marketCap":6690651440},{"date":"2022-07-29","current":22.513785,"twenty":9.38718,"median":23.633017,"eighty":45.919924,"marketCap":6709895883},{"date":"2022-08-05","current":23.159496,"twenty":9.423477,"median":23.633017,"eighty":45.919924,"marketCap":6902340315},{"date":"2022-08-12","current":22.996839,"twenty":9.477679,"median":23.677084,"eighty":45.919924,"marketCap":6269283152},{"date":"2022-08-19","current":22.819758,"twenty":9.532448,"median":23.677084,"eighty":45.919924,"marketCap":6221008384},{"date":"2022-08-26","current":21.521169,"twenty":9.589879,"median":23.677084,"eighty":45.919924,"marketCap":5866993422},{"date":"2022-09-02","current":21.143397,"twenty":9.637235,"median":23.677084,"eighty":45.919924,"marketCap":5764007251},{"date":"2022-09-09","current":21.131592,"twenty":9.656291,"median":23.677084,"eighty":45.919924,"marketCap":5760788933},{"date":"2022-09-16","current":20.24619,"twenty":9.709392,"median":23.677084,"eighty":45.919924,"marketCap":5519415095},{"date":"2022-09-23","current":19.219124,"twenty":9.737158,"median":23.677084,"eighty":45.919924,"marketCap":5239421443},{"date":"2022-09-30","current":18.510802,"twenty":9.752596,"median":23.677084,"eighty":45.919924,"marketCap":5046322373},{"date":"2022-10-07","current":18.180252,"twenty":9.809283,"median":23.677084,"eighty":45.919924,"marketCap":4956209473},{"date":"2022-10-14","current":18.475386,"twenty":9.839263,"median":23.677084,"eighty":45.919924,"marketCap":5036667419},{"date":"2022-10-21","current":19.419815,"twenty":9.921087,"median":23.677084,"eighty":45.919924,"marketCap":5294132846},{"date":"2022-10-28","current":19.632311,"twenty":9.95111,"median":23.677084,"eighty":45.919924,"marketCap":5352062567},{"date":"2022-11-04","current":17.259423,"twenty":9.977849,"median":23.677084,"eighty":45.919924,"marketCap":5309360940},{"date":"2022-11-11","current":17.615936,"twenty":10.045835,"median":23.677084,"eighty":45.919924,"marketCap":5419031822},{"date":"2022-11-18","current":17.731278,"twenty":10.09551,"median":23.677084,"eighty":45.919924,"marketCap":5454513578},{"date":"2022-11-25","current":17.762735,"twenty":10.137764,"median":23.677084,"eighty":45.919924,"marketCap":5464190420},{"date":"2022-12-02","current":18.234591,"twenty":10.262522,"median":23.677084,"eighty":45.919924,"marketCap":5609343059},{"date":"2022-12-09","current":16.535911,"twenty":10.306552,"median":23.677084,"eighty":45.919924,"marketCap":5086793561},{"date":"2022-12-16","current":16.714168,"twenty":10.501618,"median":23.677084,"eighty":45.919924,"marketCap":5141629002},{"date":"2022-12-23","current":16.598825,"twenty":10.590509,"median":23.677084,"eighty":45.919924,"marketCap":5106147246},{"date":"2022-12-30","current":16.819025,"twenty":10.667114,"median":23.677084,"eighty":45.919924,"marketCap":5173885144},{"date":"2023-01-06","current":18.108763,"twenty":10.667114,"median":23.584442,"eighty":45.49168,"marketCap":5570635688},{"date":"2023-01-13","current":17.227966,"twenty":10.667114,"median":23.503875,"eighty":45.1654,"marketCap":5299684097},{"date":"2023-01-20","current":17.542536,"twenty":10.667114,"median":23.449537,"eighty":44.010071,"marketCap":5396452523},{"date":"2023-01-27","current":18.318476,"twenty":10.667114,"median":23.314972,"eighty":43.020435,"marketCap":5635147972},{"date":"2023-02-03","current":18.402362,"twenty":10.667114,"median":23.194326,"eighty":42.458135,"marketCap":5660952885},{"date":"2023-02-10","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":42.011762,"marketCap":5687732764},{"date":"2023-02-17","current":31.096255,"twenty":10.667114,"median":23.191781,"eighty":41.420955,"marketCap":5668287524},{"date":"2023-02-24","current":30.456195,"twenty":10.667114,"median":23.191781,"eighty":41.184268,"marketCap":5551616082},{"date":"2023-03-03","current":30.491754,"twenty":10.667114,"median":23.191781,"eighty":40.984929,"marketCap":5558097829},{"date":"2023-03-10","current":29.65612,"twenty":10.667114,"median":23.191781,"eighty":40.686627,"marketCap":5405776781},{"date":"2023-03-17","current":31.202932,"twenty":10.667114,"median":23.191781,"eighty":40.243946,"marketCap":5687732764},{"date":"2023-03-24","current":32.85642,"twenty":10.667114,"median":23.191781,"eighty":39.955417,"marketCap":5989133987},{"date":"2023-03-31","current":34.509909,"twenty":10.667928,"median":23.193053,"eighty":39.475483,"marketCap":6290535211},{"date":"2023-04-06","current":35.363322,"twenty":10.667928,"median":23.193053,"eighty":39.271956,"marketCap":6446097132},{"date":"2023-04-14","current":34.918836,"twenty":10.667114,"median":23.191781,"eighty":39.023166,"marketCap":6365075298},{"date":"2023-04-21","current":33.620936,"twenty":10.667114,"median":23.191781,"eighty":38.427704,"marketCap":6128491542},{"date":"2023-04-28","current":32.305257,"twenty":10.667114,"median":23.191781,"eighty":37.395181,"marketCap":5888666913},{"date":"2023-05-05","current":34.73643,"twenty":10.667114,"median":23.191781,"eighty":37.193084,"marketCap":6331825854},{"date":"2023-05-12","current":40.911234,"twenty":10.667114,"median":23.213305,"eighty":37.526354,"marketCap":6289570343},{"date":"2023-05-19","current":41.790934,"twenty":10.666299,"median":23.203815,"eighty":38.431783,"marketCap":6424812840},{"date":"2023-05-26","current":40.308235,"twenty":10.666299,"median":23.203815,"eighty":39.03948,"marketCap":6196867124},{"date":"2023-05-31","current":40.265872,"twenty":10.666299,"median":23.203815,"eighty":39.188346,"marketCap":6190354389},{"date":"2023-06-09","current":40.98604,"twenty":10.659474,"median":23.193053,"eighty":39.394311,"marketCap":6301070880},{"date":"2023-06-16","current":40.456505,"twenty":10.636307,"median":23.23296,"eighty":39.77769,"marketCap":6219661695},{"date":"2023-06-22","current":40.265872,"twenty":10.614439,"median":23.277876,"eighty":40.236218,"marketCap":6190354389},{"date":"2023-06-26","current":42.066293,"twenty":10.603505,"median":23.311527,"eighty":40.265872,"marketCap":6467145616},{"date":"2023-07-07","current":40.943677,"twenty":10.600095,"median":23.213305,"eighty":40.520035,"marketCap":6294558145},{"date":"2023-07-14","current":40.98604,"twenty":10.600095,"median":23.213305,"eighty":40.545455,"marketCap":6301070880},{"date":"2023-07-21","current":42.087474,"twenty":10.600095,"median":23.213305,"eighty":40.680159,"marketCap":6470401984},{"date":"2023-07-28","current":41.515576,"twenty":10.600095,"median":23.213305,"eighty":40.924511,"marketCap":6382480064},{"date":"2023-08-04","current":40.24272,"twenty":10.600095,"median":23.354574,"eighty":40.932036,"marketCap":6609585096},{"date":"2023-08-11","current":40.998725,"twenty":10.600095,"median":23.481924,"eighty":40.941559,"marketCap":6733753602},{"date":"2023-08-18","current":40.707954,"twenty":10.600095,"median":23.579987,"eighty":40.983764,"marketCap":6685996485},{"date":"2023-08-25","current":42.161809,"twenty":10.600095,"median":23.703849,"eighty":41.024602,"marketCap":6924782073},{"date":"2023-09-01","current":43.402433,"twenty":10.600095,"median":23.784876,"eighty":41.205168,"marketCap":7128545776},{"date":"2023-09-08","current":42.685197,"twenty":10.600095,"median":23.881479,"eighty":41.417849,"marketCap":7010744885},{"date":"2023-09-15","current":43.169816,"twenty":10.600095,"median":23.959006,"eighty":41.704282,"marketCap":7090340081},{"date":"2023-09-22","current":41.832269,"twenty":10.600095,"median":24.063445,"eighty":41.742049,"marketCap":6870657340},{"date":"2023-09-29","current":43.402433,"twenty":10.600095,"median":24.159779,"eighty":41.859163,"marketCap":7128545776},{"date":"2023-10-06","current":42.917814,"twenty":10.600095,"median":24.411169,"eighty":41.925256,"marketCap":7048950579},{"date":"2023-10-13","current":41.173188,"twenty":10.600095,"median":24.472259,"eighty":41.970666,"marketCap":6762407873},{"date":"2023-10-20","current":40.378413,"twenty":10.600095,"median":24.601456,"eighty":42.032402,"marketCap":6631871751},{"date":"2023-10-27","current":40.688569,"twenty":10.590509,"median":24.763289,"eighty":42.053584,"marketCap":6682812677},{"date":"2023-11-03","current":67.987802,"twenty":10.590509,"median":24.82708,"eighty":42.104419,"marketCap":6259908894},{"date":"2023-11-10","current":70.993721,"twenty":10.590509,"median":24.916894,"eighty":42.169563,"marketCap":6536675855},{"date":"2023-11-17","current":70.858623,"twenty":10.590509,"median":25.114925,"eighty":42.251018,"marketCap":6524236890},{"date":"2023-11-24","current":73.222829,"twenty":10.590509,"median":25.234082,"eighty":42.431195,"marketCap":6741918769},{"date":"2023-12-01","current":73.661896,"twenty":10.590509,"median":25.380185,"eighty":42.822269,"marketCap":6782345404},{"date":"2023-12-08","current":74.269835,"twenty":10.594875,"median":25.475549,"eighty":42.99923,"marketCap":6838320744},{"date":"2023-12-15","current":78.728051,"twenty":10.594875,"median":25.683605,"eighty":43.169816,"marketCap":7248806574},{"date":"2023-12-22","current":79.302215,"twenty":10.594875,"median":25.809174,"eighty":43.432834,"marketCap":7301672173},{"date":"2023-12-29","current":81.497549,"twenty":10.590509,"median":25.871438,"eighty":43.801759,"marketCap":7503805346},{"date":"2024-01-05","current":79.741282,"twenty":10.586142,"median":26.026128,"eighty":45.173557,"marketCap":7342098807},{"date":"2024-01-12","current":75.688358,"twenty":10.586142,"median":26.123266,"eighty":45.499837,"marketCap":6968929872},{"date":"2024-01-19","current":75.215517,"twenty":10.581776,"median":26.310309,"eighty":46.429737,"marketCap":6925393496},{"date":"2024-01-26","current":74.607578,"twenty":10.586142,"median":26.757641,"eighty":47.070063,"marketCap":6869418156},{"date":"2024-02-02","current":73.45925,"twenty":10.586142,"median":26.8819,"eighty":48.970648,"marketCap":6763686957},{"date":"2024-02-09","current":29.434352,"twenty":10.586142,"median":27.133306,"eighty":50.736642,"marketCap":6115428204},{"date":"2024-02-16","current":30.047264,"twenty":10.666299,"median":27.737543,"eighty":50.736642,"marketCap":6242769792},{"date":"2024-02-23","current":30.222382,"twenty":10.755729,"median":28.081886,"eighty":50.736642,"marketCap":6279153103},{"date":"2024-03-01","current":31.958965,"twenty":12.580654,"median":28.465994,"eighty":50.389968,"marketCap":6639954272},{"date":"2024-03-08","current":32.236234,"twenty":14.477572,"median":28.687196,"eighty":50.389968,"marketCap":6697561181},{"date":"2024-03-15","current":32.995077,"twenty":15.693391,"median":29.087177,"eighty":50.389968,"marketCap":6855222195},{"date":"2024-03-22","current":34.906778,"twenty":16.21505,"median":29.378454,"eighty":50.389968,"marketCap":7252406675},{"date":"2024-03-28","current":34.819219,"twenty":16.431775,"median":29.448945,"eighty":50.389968,"marketCap":7234215019},{"date":"2024-04-05","current":34.279273,"twenty":16.579951,"median":29.605173,"eighty":50.736642,"marketCap":7122033143},{"date":"2024-04-12","current":33.05345,"twenty":16.813772,"median":29.772048,"eighty":50.736642,"marketCap":6867349966},{"date":"2024-04-19","current":31.911299,"twenty":16.916749,"median":30.058488,"eighty":50.736642,"marketCap":6630050987},{"date":"2024-04-26","current":33.386966,"twenty":17.091652,"median":30.249439,"eighty":50.389968,"marketCap":6936642941},{"date":"2024-05-03","current":31.422916,"twenty":17.176551,"median":30.506341,"eighty":50.389968,"marketCap":6443394612},{"date":"2024-05-10","current":30.911512,"twenty":17.328629,"median":30.882901,"eighty":50.389968,"marketCap":6338529239},{"date":"2024-05-17","current":30.158612,"twenty":17.488992,"median":30.882901,"eighty":50.389968,"marketCap":6184144105},{"date":"2024-05-24","current":28.993748,"twenty":17.580284,"median":30.882901,"eighty":50.389968,"marketCap":5945284088},{"date":"2024-05-31","current":30.812073,"twenty":17.615936,"median":30.882901,"eighty":50.389968,"marketCap":6318138749},{"date":"2024-06-07","current":31.08198,"twenty":17.668364,"median":30.954522,"eighty":50.389968,"marketCap":6373484363},{"date":"2024-06-14","current":30.883101,"twenty":17.731278,"median":31.025137,"eighty":50.389968,"marketCap":6332703384},{"date":"2024-06-21","current":31.536561,"twenty":17.769898,"median":31.042917,"eighty":50.736642,"marketCap":6466698028},{"date":"2024-06-28","current":31.920114,"twenty":17.8613,"median":31.103323,"eighty":50.736642,"marketCap":6545347058},{"date":"2024-07-05","current":31.394505,"twenty":18.024877,"median":31.149457,"eighty":50.736642,"marketCap":6437568758},{"date":"2024-07-12","current":31.820674,"twenty":18.175107,"median":31.199278,"eighty":50.736642,"marketCap":6524956569},{"date":"2024-07-19","current":32.104788,"twenty":18.272126,"median":31.292005,"eighty":50.736642,"marketCap":6583215110},{"date":"2024-07-26","current":33.227035,"twenty":18.414252,"median":31.360962,"eighty":50.736642,"marketCap":6813336346},{"date":"2024-08-02","current":34.335076,"twenty":18.480333,"median":31.430019,"eighty":50.736642,"marketCap":7040544655},{"date":"2024-08-09","current":21.981185,"twenty":18.723299,"median":31.444483,"eighty":50.736642,"marketCap":7693239023},{"date":"2024-08-16","current":21.475871,"twenty":18.914042,"median":31.444483,"eighty":50.736642,"marketCap":7516382953},{"date":"2024-08-23","current":21.09281,"twenty":19.069994,"median":31.444483,"eighty":50.736642,"marketCap":7382314643},{"date":"2024-08-30","current":21.215063,"twenty":19.173593,"median":31.444483,"eighty":50.736642,"marketCap":7425102401},{"date":"2024-09-06","current":20.497842,"twenty":19.271067,"median":31.444483,"eighty":50.736642,"marketCap":7174080883},{"date":"2024-09-13","current":21.565523,"twenty":19.391482,"median":31.444483,"eighty":50.736642,"marketCap":7547760643},{"date":"2024-09-20","current":21.532922,"twenty":19.566201,"median":31.444483,"eighty":50.736642,"marketCap":7536350574},{"date":"2024-09-27","current":21.158012,"twenty":19.756599,"median":31.444483,"eighty":50.736642,"marketCap":7405134781},{"date":"2024-10-04","current":21.728528,"twenty":20.051881,"median":31.444483,"eighty":50.736642,"marketCap":7604810988},{"date":"2024-10-11","current":21.378068,"twenty":20.260356,"median":31.444483,"eighty":50.736642,"marketCap":7482152746},{"date":"2024-10-18","current":23.554181,"twenty":20.577253,"median":31.444483,"eighty":50.736642,"marketCap":8243774852},{"date":"2024-10-25","current":22.714707,"twenty":20.830566,"median":31.444483,"eighty":50.736642,"marketCap":7949965575},{"date":"2024-11-01","current":20.868399,"twenty":20.870141,"median":31.444483,"eighty":50.736642,"marketCap":9743956162},{"date":"2024-11-08","current":22.171145,"twenty":20.970556,"median":31.444483,"eighty":50.736642,"marketCap":10352239475},{"date":"2024-11-15","current":21.070232,"twenty":21.016922,"median":31.444483,"eighty":50.736642,"marketCap":9838197239},{"date":"2024-11-22","current":21.779709,"twenty":21.079263,"median":31.444483,"eighty":50.736642,"marketCap":10169468902},{"date":"2024-11-29","current":22.299584,"twenty":21.136314,"median":31.444483,"eighty":50.736642,"marketCap":10412211069},{"date":"2024-12-06","current":21.908149,"twenty":21.209839,"median":31.444483,"eighty":50.736642,"marketCap":10229440496},{"date":"2024-12-13","current":21.424971,"twenty":21.270039,"median":31.444483,"eighty":50.736642,"marketCap":10003833070},{"date":"2024-12-20","current":20.360756,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9506925575},{"date":"2024-12-27","current":20.678797,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9655426666},{"date":"2025-01-03","current":20.776656,"twenty":21.286762,"median":31.444483,"eighty":50.736642,"marketCap":9701119309},{"date":"2025-01-10","current":22.030472,"twenty":21.317067,"median":31.451844,"eighty":51.083315,"marketCap":10286556300},{"date":"2025-01-17","current":22.140564,"twenty":21.392738,"median":31.451844,"eighty":51.083315,"marketCap":10337960524},{"date":"2025-01-24","current":19.804184,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9247048667},{"date":"2025-01-31","current":20.275129,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9466944513},{"date":"2025-02-07","current":20.476963,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9561185589},{"date":"2025-02-14","current":18.792386,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9795850750},{"date":"2025-02-21","current":19.785698,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10313631432},{"date":"2025-02-28","current":20.773641,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10828613300},{"date":"2025-03-07","current":20.714579,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10797826341},{"date":"2025-03-14","current":19.678313,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10257655142},{"date":"2025-03-21","current":19.84476,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10344418392},{"date":"2025-03-28","current":19.705159,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":10271649215},{"date":"2025-04-04","current":18.561508,"twenty":21.424971,"median":31.451844,"eighty":51.429988,"marketCap":9675501726},{"date":"2025-04-11","current":18.958833,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":9882613999},{"date":"2025-04-17","current":19.324707,"twenty":21.420049,"median":31.451844,"eighty":51.083315,"marketCap":10073332113},{"date":"2025-04-25","current":19.986841,"twenty":21.378068,"median":31.451844,"eighty":51.429988,"marketCap":10418480823},{"date":"2025-05-02","current":21.145576,"twenty":21.26595,"median":31.451844,"eighty":51.429988,"marketCap":11022491066},{"date":"2025-05-09","current":19.314028,"twenty":21.215063,"median":31.451844,"eighty":51.429988,"marketCap":10067765198},{"date":"2025-05-16","current":19.238052,"twenty":21.149861,"median":31.451844,"eighty":51.429988,"marketCap":12380955912},{"date":"2025-05-23","current":18.161738,"twenty":21.100813,"median":31.451844,"eighty":51.429988,"marketCap":11688276880},{"date":"2025-05-30","current":18.051564,"twenty":21.052058,"median":31.451844,"eighty":51.429988,"marketCap":11617372728},{"date":"2025-06-06","current":17.954102,"twenty":21.011307,"median":31.451844,"eighty":51.429988,"marketCap":11554649823},{"date":"2025-06-13","current":17.704092,"twenty":20.970556,"median":31.451844,"eighty":51.429988,"marketCap":11393751938},{"date":"2025-06-20","current":17.263397,"twenty":20.919812,"median":31.451844,"eighty":52.534404,"marketCap":11110135327},{"date":"2025-06-27","current":18.259199,"twenty":20.836957,"median":31.451844,"eighty":52.534404,"marketCap":11750999785},{"date":"2025-07-03","current":19.555861,"twenty":20.776053,"median":31.451844,"eighty":52.534404,"marketCap":12585487122},{"date":"2025-07-11","current":19.14059,"twenty":20.723755,"median":31.451844,"eighty":52.534404,"marketCap":12318233007},{"date":"2025-07-18","current":19.013466,"twenty":20.683176,"median":31.451844,"eighty":52.534404,"marketCap":12236420523},{"date":"2025-07-25","current":18.979567,"twenty":20.586623,"median":31.451844,"eighty":52.534404,"marketCap":12214603861},{"date":"2025-08-01","current":16.188856,"twenty":20.513914,"median":31.451844,"eighty":52.534404,"marketCap":9750515310},{"date":"2025-08-08","current":16.711798,"twenty":20.476963,"median":31.451844,"eighty":52.534404,"marketCap":10065482260},{"date":"2025-08-15","current":17.194513,"twenty":20.30571,"median":31.451844,"eighty":52.534404,"marketCap":10356220982},{"date":"2025-08-22","current":17.301783,"twenty":20.251749,"median":31.451844,"eighty":52.534404,"marketCap":10420829587},{"date":"2025-08-29","current":16.939747,"twenty":20.21434,"median":31.451844,"eighty":52.534404,"marketCap":10202775545},{"date":"2025-09-05","current":16.707328,"twenty":20.146713,"median":31.458689,"eighty":53.63882,"marketCap":10062790234},{"date":"2025-09-12","current":17.462689,"twenty":19.984406,"median":31.451844,"eighty":52.534404,"marketCap":10517742495},{"date":"2025-09-19","current":18.079492,"twenty":19.948593,"median":31.451844,"eighty":52.534404,"marketCap":10889241974},{"date":"2025-09-26","current":17.292844,"twenty":19.877101,"median":31.451844,"eighty":52.534404,"marketCap":10415445537},{"date":"2025-10-03","current":18.481755,"twenty":19.840807,"median":31.451844,"eighty":52.534404,"marketCap":11131524243},{"date":"2025-10-10","current":17.239209,"twenty":19.803707,"median":31.451844,"eighty":52.534404,"marketCap":10383141234},{"date":"2025-10-17","current":17.525263,"twenty":19.742534,"median":31.451844,"eighty":52.534404,"marketCap":10555430848},{"date":"2025-10-24","current":17.006791,"twenty":19.679289,"median":31.451844,"eighty":52.534404,"marketCap":10243155924},{"date":"2025-10-31","current":17.404584,"twenty":19.615895,"median":31.451844,"eighty":52.534404,"marketCap":10482746167},{"date":"2025-11-07","current":16.202116,"twenty":19.555861,"median":31.437122,"eighty":52.534404,"marketCap":10983462856},{"date":"2025-11-14","current":16.817637,"twenty":19.509455,"median":31.380299,"eighty":52.534404,"marketCap":11400726764},{"date":"2025-11-21","current":16.591284,"twenty":19.373439,"median":31.295065,"eighty":52.534404,"marketCap":11247281327},{"date":"2025-11-28","current":17.540379,"twenty":19.314266,"median":31.202932,"eighty":52.534404,"marketCap":11890675352},{"date":"2025-12-05","current":17.619801,"twenty":19.287595,"median":31.161149,"eighty":52.534404,"marketCap":11944515856},{"date":"2025-12-12","current":16.436411,"twenty":19.234266,"median":31.110391,"eighty":52.534404,"marketCap":11142292344},{"date":"2025-12-19","current":16.905002,"twenty":19.13508,"median":31.060696,"eighty":52.534404,"marketCap":11459951318},{"date":"2025-12-26","current":18.469618,"twenty":19.091517,"median":30.989578,"eighty":52.534404,"marketCap":12520609251},{"date":"2026-01-02","current":17.405361,"twenty":19.012619,"median":30.926871,"eighty":52.534404,"marketCap":11799146495},{"date":"2026-01-09","current":17.532437,"twenty":18.97458,"median":30.882901,"eighty":52.534404,"marketCap":11885291302},{"date":"2026-01-16","current":18.044709,"twenty":18.899845,"median":30.670016,"eighty":50.234126,"marketCap":12232562554},{"date":"2026-01-23","current":17.671425,"twenty":18.838561,"median":30.491754,"eighty":50.234126,"marketCap":11979512184},{"date":"2026-01-30","current":16.78984,"twenty":18.766673,"median":30.249439,"eighty":50.234126,"marketCap":11381882587},{"date":"2026-02-06","current":16.825579,"twenty":18.695068,"median":30.105636,"eighty":50.234126,"marketCap":11406110814},{"date":"2026-02-13","current":14.170695,"twenty":18.554438,"median":29.889985,"eighty":43.40631,"marketCap":11089561020},{"date":"2026-02-20","current":14.65522,"twenty":18.504467,"median":29.831882,"eighty":43.092277,"marketCap":11468735706},{"date":"2026-02-27","current":14.695044,"twenty":18.475686,"median":29.755401,"eighty":42.964338,"marketCap":11499900748},{"date":"2026-03-06","current":13.699445,"twenty":18.456655,"median":29.521911,"eighty":42.638674,"marketCap":10720774681},{"date":"2026-03-13","current":13.66294,"twenty":18.41075,"median":29.44758,"eighty":42.285872,"marketCap":10692206726},{"date":"2026-03-20","current":13.692808,"twenty":18.342542,"median":29.115776,"eighty":42.161809,"marketCap":10715580508},{"date":"2026-03-27","current":14.057861,"twenty":18.259199,"median":28.993748,"eighty":42.049347,"marketCap":11001260066},{"date":"2026-04-02","current":14.615396,"twenty":18.234428,"median":28.687196,"eighty":41.878613,"marketCap":11437570663},{"date":"2026-04-10","current":15.070053,"twenty":18.171384,"median":28.383043,"eighty":41.791447,"marketCap":11793371567},{"date":"2026-04-17","current":14.728231,"twenty":18.108763,"median":27.097303,"eighty":41.696576,"marketCap":11525871617},{"date":"2026-04-24","current":14.947003,"twenty":18.071285,"median":24.862085,"eighty":41.545375,"marketCap":11697076412},{"date":"2026-05-01","current":14.430918,"twenty":18.014311,"median":23.686826,"eighty":41.386833,"marketCap":11293203416},{"date":"2026-05-08","current":13.936676,"twenty":17.953577,"median":23.497129,"eighty":41.036876,"marketCap":11615118385},{"date":"2026-05-15","current":15.411472,"twenty":17.905982,"median":23.228171,"eighty":40.949874,"marketCap":12844244741},{"date":"2026-05-22","current":14.974161,"twenty":17.865495,"median":23.159496,"eighty":40.903688,"marketCap":12479779870},{"date":"2026-05-29","current":15.51703,"twenty":17.794093,"median":23.031304,"eighty":40.696323,"marketCap":12932219020},{"date":"2026-06-05","current":15.830689,"twenty":17.72762,"median":22.976544,"eighty":40.649215,"marketCap":13193628306},{"date":"2026-06-12","current":16.135299,"twenty":17.677365,"median":22.910312,"eighty":40.520049,"marketCap":13447496940},{"date":"2026-06-18","current":15.815609,"twenty":17.660523,"median":22.794995,"eighty":40.339215,"marketCap":13181060552},{"date":"2026-06-26","current":16.053868,"twenty":17.618489,"median":22.608952,"eighty":40.029841,"marketCap":13379631068},{"date":"2026-07-02","current":16.274032,"twenty":17.615894,"median":22.524547,"eighty":39.347145,"marketCap":13563120278},{"date":"2026-07-10","current":17.221039,"twenty":17.587238,"median":22.397431,"eighty":37.962212,"marketCap":14352375239},{"date":"2026-07-17","current":16.792775,"twenty":17.541673,"median":22.296526,"eighty":36.938865,"marketCap":13995451021},{"date":"2026-07-24","current":16.783727,"twenty":17.523027,"median":22.203786,"eighty":36.596054,"marketCap":13987910368},{"date":"2026-07-31","current":16.880237,"twenty":17.497396,"median":22.134447,"eighty":36.439357,"marketCap":14068343995},{"date":"2026-08-07","current":15.028885,"twenty":17.477953,"median":21.975427,"eighty":36.110725,"marketCap":12934204322},{"date":"2026-08-14","current":14.571109,"twenty":17.441235,"median":21.877568,"eighty":35.783336,"marketCap":12540231432},{"date":"2026-08-21","current":15.457871,"twenty":17.393,"median":21.779709,"eighty":35.430434,"marketCap":13303399043}],"updateTime":1787495511058},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EXEL\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2633180581","title":"Exelixis (EXEL) Gets a Hold from Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2633180581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633180581?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067034,"startTime":"0","endTime":"0","summary":"In a report released today, from Wells Fargo maintained a Hold rating on Exelixis, with a price target of $40.00. In addition to Wells Fargo, Exeli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/exelixis-exel-gets-a-hold-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/exelixis-exel-gets-a-hold-from-wells-fargo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2361045086.USD","LU2361044949.HKD","IE00B19Z3B42.SGD","LU0106831901.USD","LU0310800379.SGD","IE000M9KFDE8.USD","BK4207","LU2361044865.SGD","IE00B7SZLL34.SGD","LU0942090050.USD","LU0980610538.SGD","LU0029864427.USD","LU0154236417.USD","LU1074936037.SGD","BK4532","LU0048573561.USD","LU1035773651.USD","LU1814569148.SGD","LU1201861249.SGD","LU1069347547.HKD","LU0052756011.USD","BK4139","BK4588","LU0310799852.SGD","LU2236285917.USD","BK4582","IE0002270589.USD","LU1668664300.SGD","LU1894683264.USD","EXEL","LU0130517989.USD","LU0417517546.SGD","LU0128525689.USD","LU0211328371.USD","LU0130102774.USD","LU0289960550.SGD","LU0320765489.SGD","PGF","LU0149725797.USD","IE00B19Z3581.USD","LU0072461881.USD","LU1280957306.USD","LU1894683348.USD","LU0208291251.USD","LU0175139822.USD","LU0742534661.SGD","LU0251131958.USD","BK4559","LU0787776722.HKD","LU2461242641.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633819251","title":"Exelixis Kept at Hold as Cabo Momentum Offsets Pipeline Uncertainty; Price Target Raised from $49 to $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2633819251","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633819251?lang=en_us&edition=fundamental","pubTime":"2026-05-06 18:29","pubTimestamp":1778063348,"startTime":"0","endTime":"0","summary":"In a report released today, Sean Laaman from Morgan Stanley maintained a Hold rating on Exelixis, with a price target of $50.00. Sean Laaman has gi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/exelixis-kept-at-hold-as-cabo-momentum-offsets-pipeline-uncertainty-price-target-raised-from-49-to-50-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/exelixis-kept-at-hold-as-cabo-momentum-offsets-pipeline-uncertainty-price-target-raised-from-49-to-50-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633885188","title":"Analysts Offer Insights on Healthcare Companies: Lemaitre Vascular (LMAT), Henry Schein (HSIC) and Exelixis (EXEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633885188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633885188?lang=en_us&edition=fundamental","pubTime":"2026-05-06 16:50","pubTimestamp":1778057410,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lemaitre Vascular (LMAT), Henry Schein (HSIC) and Exelixis (EXEL)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-lemaitre-vascular-lmat-henry-schein-hsic-and-exelixis-exel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-lemaitre-vascular-lmat-henry-schein-hsic-and-exelixis-exel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LMAT","LABU","XLV","XBI","BK4585","HSIC","BK4082","BK4532","LU0029874061.USD","BK4175","BK4137","BK4581","LU0128526141.USD","BK4139","EXEL","HCSG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633146909","title":"Margin Gains From Oncology Portfolio Might Change The Case For Investing In Exelixis (EXEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633146909","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633146909?lang=en_us&edition=fundamental","pubTime":"2026-05-06 14:30","pubTimestamp":1778049034,"startTime":"0","endTime":"0","summary":"Exelixis, Inc. has reported first-quarter 2026 results, with revenue of US$610.81 million and net income of US$210.47 million, alongside higher basic and diluted earnings per share than a year earlier.\nThe widening gap between revenue and profit compared with the prior-year quarter points to improving operational efficiency and earnings power from Exelixis’s oncology portfolio.\nNext, we’ll explore how this margin improvement and earnings growth intersect with Exelixis’s existing investment...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/margin-gains-from-oncology-portfolio-might-change-the-case-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/margin-gains-from-oncology-portfolio-might-change-the-case-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","EXEL","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633970031","title":"Exelixis Price Target Raised to $55 on Cabo Strength, Buyback-Driven EPS Growth, and Zanzalintinib Upside Optionality","url":"https://stock-news.laohu8.com/highlight/detail?id=2633970031","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633970031?lang=en_us&edition=fundamental","pubTime":"2026-05-06 12:25","pubTimestamp":1778041526,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Yaron Werber has assigned their bullish stance on EXEL stock, giving a Buy rating today. Yaron Werber has given his Buy rating due...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/exelixis-price-target-raised-to-55-on-cabo-strength-buyback-driven-eps-growth-and-zanzalintinib-upside-optionality-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/exelixis-price-target-raised-to-55-on-cabo-strength-buyback-driven-eps-growth-and-zanzalintinib-upside-optionality-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633927721","title":"Exelixis Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633927721","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633927721?lang=en_us&edition=fundamental","pubTime":"2026-05-06 05:37","pubTimestamp":1778017020,"startTime":"0","endTime":"0","summary":"Exelixis Inc reports results for the quarter ended March 31 - Earnings SummaryExelixis Inc EXEL.OQ reported quarterly adjusted earnings of 79 cents per share for the quarter ended March 31, higher tha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL8N41I3KC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633226549","title":"Exelixis Posts Strong Q1 Results, Expands Share Buybacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2633226549","media":"TIPRANKS","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633226549?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:56","pubTimestamp":1778014589,"startTime":"0","endTime":"0","summary":"Exelixis ( ($EXEL) ) just unveiled an announcement. On May 5, 2026, Exelixis reported first quarter 2026 revenues of $610.8 million, up from $555.4...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/exelixis-posts-strong-q1-results-expands-share-buybacks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/exelixis-posts-strong-q1-results-expands-share-buybacks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","EXEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633924061","title":"Exelixis Q1 revenue slightly beats estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2633924061","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633924061?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:53","pubTimestamp":1778014380,"startTime":"0","endTime":"0","summary":"Exelixis Q1 revenue slightly beats estimatesOverviewU.S. oncology drugmaker's Q1 revenue rose yr/yr, slightly beating analyst expectationsAdjusted net income for Q1 beat analyst expectationsCompany an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nL1N41I1C4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","EXEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633218099","title":"GUIDANCE: (EXEL) Exelixis Expects Full Year 2026 Revenue Range $2.53B - $2.63B, vs. FactSet Est of $2.58B","url":"https://stock-news.laohu8.com/highlight/detail?id=2633218099","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633218099?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:21","pubTimestamp":1778012506,"startTime":"0","endTime":"0","summary":"GUIDANCE: (EXEL) Exelixis Expects Full Year 2026 Revenue Range $2.53B - $2.63B, vs. FactSet Est of $2.58B","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633929102","title":"Exelixis Q1 FY26 GAAP diluted EPS climbs to $0.79; revenue rises to $610.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633929102","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633929102?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:19","pubTimestamp":1778012344,"startTime":"0","endTime":"0","summary":"Exelixis posted Q1 revenue of USD 610.8 million, lifting GAAP net income to USD 210.5 million.Diluted EPS climbed to USD 0.79, while U.S. cabozantinib franchise net product revenue totaled USD 555 million.Collaboration revenue increased to USD 55.8 million on higher ex-U.S. cabozantinib royalties from Ipsen and higher milestone-related revenue recognized.FDA accepted zanzalintinib NDA in previously treated metastatic colorectal cancer, setting a Dec. 3, 2026 action date; topline results from STELLAR-304 expected in second half of 2026.Board authorized an additional USD 750 million share repurchase program through end-2027, while maintaining 2026 total revenue outlook of USD 2.525 billion to USD 2.625 billion.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDL3RbbRZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EXEL","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633441926","title":"Exelixis Q1 Adj. EPS $0.87 Beats $0.70 Estimate, Sales $610.812M Beat $605.196M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633441926","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633441926?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:10","pubTimestamp":1778011825,"startTime":"0","endTime":"0","summary":"Exelixis (NASDAQ:EXEL) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.70 by 24.29 percent. This is a 40.32 percent increase over earnings of $0.62 per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52302154/exelixis-q1-adj-eps-0-87-beats-0-70-estimate-sales-610-812m-beat-605-196m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Exelixis Q1 Adj. EPS $0.87 Beats $0.70 Estimate, Sales $610.812M Beat $605.196M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633926351","title":"BRIEF-Exelixis Q1 Revenue USD 610.8 Million Vs. IBES Estimate USD 605.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633926351","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633926351?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:05","pubTimestamp":1778011548,"startTime":"0","endTime":"0","summary":"BRIEF-Exelixis Q1 Revenue USD 610.8 Million Vs. IBES Estimate USD 605.2 Million\n\n\nMay 05 (Reuters) - Exelixis Q1 net income USD 210.5 million.\n\nQ1 adjusted net income USD 232.8 million vs. IBES estimate USD 190.1 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXB1151F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633924791","title":"Exelixis Guidance 2026 Total Revenues $2.525 Billion - $2.625 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2633924791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633924791?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:05","pubTimestamp":1778011505,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXB1151F:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","EXEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633924471","title":"Exelixis Inc - Maintains 2026 Financial Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2633924471","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633924471?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:05","pubTimestamp":1778011505,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXB1151F:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","EXEL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633592424","title":"Exelixis Inc - in May, Board Authorizes $750 Mln Stock Repurchase Program in May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633592424","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633592424?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:05","pubTimestamp":1778011505,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXB1151F:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4139","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633292447","title":"Exelixis Inc - Initiates Stellar-201 Phase 2 Trial of Zanzalintinib in Recurrent Meningioma","url":"https://stock-news.laohu8.com/highlight/detail?id=2633292447","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633292447?lang=en_us&edition=fundamental","pubTime":"2026-05-06 04:05","pubTimestamp":1778011505,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nPLXB1151F:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4532","BK4139","EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179336002","title":"Earning Preview: Exelixis Q1 revenue is expected to increase by 21.51%, and institutional views are cautious with Hold calls dominant","url":"https://stock-news.laohu8.com/highlight/detail?id=1179336002","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179336002?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:26","pubTimestamp":1777375566,"startTime":"0","endTime":"0","summary":"Abstract Exelixis is scheduled to report its quarterly results on May 5, 2026, Post Market; markets expect higher year-over-year revenue and earnings, with investors watching operating leverage,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Exelixis Q1 revenue is expected to increase by 21.51%, and institutional views are cautious with Hold calls dominant","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXEL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629085970","title":"Exelixis and Merck Advance Key Phase 3 Kidney Cancer Trial, Setting Up a New Catalyst for EXEL","url":"https://stock-news.laohu8.com/highlight/detail?id=2629085970","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629085970?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:32","pubTimestamp":1776961963,"startTime":"0","endTime":"0","summary":"Exelixis ($EXEL) announced an update on their ongoing clinical study. The LITESPARK-034 study, also known as MK-6482-034, is a large Phase 3 trial ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/exelixis-and-merck-advance-key-phase-3-kidney-cancer-trial-setting-up-a-new-catalyst-for-exel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/exelixis-and-merck-advance-key-phase-3-kidney-cancer-trial-setting-up-a-new-catalyst-for-exel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0006306889.USD","LU2023250504.SGD","LU0203347892.USD","LU0942090050.USD","LU0980610538.SGD","LU1934455863.HKD","BK4516","IE00BJJMRZ35.SGD","LU0211331839.USD","SG9999014542.SGD","LU1116320901.HKD","LU0234572021.USD","LU1093756325.SGD","LU0648001328.SGD","LU1989772840.SGD","LU1066051498.USD","LU0859254822.USD","LU1585245621.USD","LU1934455277.USD","LU1989772923.USD","LU0208291251.USD","SG9999013999.USD","LU0106261372.USD","IE00BN8TJ469.HKD","LU1941712348.USD","LU0265550359.USD","LU0265550946.USD","IE00BBT3K403.USD","LU0477156953.USD","LU0868494708.USD","SG9999001176.SGD","LU0070302665.USD","BK4007","LU1291159041.SGD","BK4532","LU1035773651.USD","LU2106854487.HKD","LU1201861249.SGD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU2125154935.USD","LU1941712264.USD","LU1116320737.USD","BK4533","LU0130517989.USD","SG9999001176.USD","IE00B2B36J28.USD","LU2089984988.USD","IE00BLSP4239.USD","LU1057294990.SGD","LU1162221912.USD","LU2125154778.USD","BK4559","SG9999014567.USD","LU1929549753.HKD","LU1061106388.HKD","IE00BJT1NW94.SGD","IE000M9KFDE8.USD","LU0289739699.SGD","BK4585","LU1571399168.USD","LU2324357040.USD","LU1430594728.SGD","LU1069347547.HKD","LU0122379950.USD","MRK","LU0058720904.USD","SG9999015358.SGD","LU0861579265.USD","LU0985320562.USD","LU0965509010.AUD","EXEL","LU0203345920.USD","LU1699723380.USD","LU0266013472.USD","SG9999002224.SGD","IE00B1BXHZ80.USD","LU0320765489.SGD","LU1093756168.USD","LU2468319806.SGD","LU0098860793.USD","SG9999015341.SGD","BK4534","LU1037948541.HKD","LU0965508806.USD","LU0965509101.SGD","LU0238689110.USD","LU1037948897.HKD","LU2461242641.AUD","LU2361045086.USD","LU2361044949.HKD","SG9999002232.USD","LU2361044865.SGD","LU0432979614.USD","LU1934455194.USD","LU1066051811.HKD","LU0868494617.USD","LU0965509283.SGD","LU1023059063.AUD","IE0009355771.USD","IE0002141913.USD","BK4139","BK4588","SG9999014559.SGD","LU2112291526.USD","LU2360032135.SGD","LU1974910355.USD","LU1989771016.USD","LU0130102774.USD","IE00B4R5TH58.HKD","LU2023250843.SGD","LU2357627491.SGD","LU1983299246.USD","BK4550","LU1066053197.SGD","IE00BLSP4452.SGD","SGXZ57979304.SGD","SG9999014575.USD","LU1917777945.USD","LU0320765646.SGD","LU1066051225.USD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629006050","title":"Does Exelixis (EXEL) Gain Quiet Competitive Leverage From a Rival’s Kidney Cancer Setback?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629006050","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629006050?lang=en_us&edition=fundamental","pubTime":"2026-04-23 14:11","pubTimestamp":1776924676,"startTime":"0","endTime":"0","summary":"Earlier this week, Exelixis drew attention after a report said a rival’s triple‑drug kidney cancer regimen failed in a Dow Jones pharma update, highlighting Exelixis as a key competitor in this treatment area.\nThis setback for a competing approach subtly improves the perceived competitive position of Exelixis’s kidney cancer franchise at a time when oncology differentiation is critical.\nWe’ll now explore how a rival’s failed kidney cancer regimen may influence Exelixis’s existing oncology...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/28338-main-header/1585188087119"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/does-exelixis-exel-gain-quiet-competitive-leverage-from-a-ri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-exel/exelixis/news/does-exelixis-exel-gain-quiet-competitive-leverage-from-a-ri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["EXEL","BK4532","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629098032","title":"The Tactical Trio Blueprint For Solid Balance Sheet And Fundamentals","url":"https://stock-news.laohu8.com/highlight/detail?id=2629098032","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629098032?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:11","pubTimestamp":1776823873,"startTime":"0","endTime":"0","summary":"With inflation, energy shocks and bond yields all in focus, many investors are looking for companies that are not only surviving the noise but also backed by strong fundamentals. A solid balance sheet and high return on equity can help show which businesses are using capital efficiently while keeping financial risk in check. That is exactly what the Solid Balance Sheet and Fundamentals screener is built to highlight. In this article, you will see three stocks filtered by that approach, along...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/343729-main-header/1756255630650","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/343729-main-header/1756255630650"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/food-beverage-tobacco/nasdaq-mnst/monster-beverage/news/the-tactical-trio-blueprint-for-solid-balance-sheet-and-fund","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/food-beverage-tobacco/nasdaq-mnst/monster-beverage/news/the-tactical-trio-blueprint-for-solid-balance-sheet-and-fund","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PTIR","BK4533","PLTZ","SGXZ99366536.SGD","SGXZ81514606.USD","LU0345770993.USD","PLTA","BK4177","BK4585","LU2326559502.SGD","PLTI","LU0077335932.USD","LU1069344957.HKD","SGXZ51526630.SGD","PLTU","LU1035775433.USD","MNST","PLTY","PLTG","LU0079474960.USD","LU0345774631.USD","LU0234570918.USD","PLT","IE00B19Z9Z06.USD","BK4504","BK4613","BK4023","LU1861559042.SGD","PLTW","PLYY","EXEL","IE00BZ9MQY76.HKD","PLOO","LU0345770308.USD","BK4588","LU0345774391.USD","LU1429558221.USD","PLTD","LU1435385759.SGD","BK4543","IE00B19Z9505.USD","LU1861558580.USD","BK4139","BK4547","IE00B19Z9P08.USD","LU0342679015.USD","BK4532","IE00B894F039.SGD","PLTR"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":6,"totalSize":141,"code":"91000000","status":"200"}]}}